Targeting CB2R in astrocytes for Parkinson's disease therapy: unraveling the Foxg1-mediated neuroprotective mechanism through autophagy-mediated NLRP3 degradation.

"Declarations Ethics approval and consent to participateThe current study does not involve human participants, human tissue or human data. All animal procedures were conducted in accordance with the Chinese Guidelines of Animal Care and Welfare, as well as the guideline of the Institutional Animal Care and Use Committee of Nanchang University. Consent for publicationAll authors have read and approved the final manuscript. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding This work was supported by National Natural Science Foundation of China (82360544, 82360227); Natural Science Foundation of Jiangxi Province (20232ACB206045, 20232BAB206060); Nanchang University Second Affiliated Hospital Fund Incubation Plan Project (2023YNFY12011)."